New drug EB-1020 put to the test: will it be the next 'High'?
NCT ID NCT02144415
First seen Apr 21, 2026 · Last updated Jun 09, 2026 · Updated 10 times
Summary
This study looked at whether the experimental drug EB-1020 could be abused like other stimulants. It involved 80 healthy adults who occasionally use stimulants recreationally. Participants received single doses of EB-1020, a placebo (dummy pill), or d-amphetamine (a known stimulant) and rated how much they liked the drug's effects. The goal was to see if EB-1020 produces a 'high' similar to other stimulants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vince and Associates Clinical Research, Inc.
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.